Ligand validation:4CVU

NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose

NAG is a Ligand Of Interest in 4CVU designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
4CVU_NAG_A_1003	50%	42%	0.142	0.892	0.93	1.36	1	1	0	0	100%	0.9333
4CVU_NAG_A_1004	46%	58%	0.144	0.879	0.48	1.12	-	1	0	0	100%	0.9333
4CVU_NAG_A_1007	41%	58%	0.181	0.896	0.5	1.08	-	-	0	0	100%	0.9333
4CVU_NAG_A_1001	37%	44%	0.203	0.901	0.96	1.22	1	1	0	0	100%	0.9333
4CVU_NAG_A_1002	12%	32%	0.295	0.84	0.66	2.14	-	7	0	0	93%	0.9333
4CVU_NAG_A_1006	12%	59%	0.31	0.841	0.54	1.02	-	1	0	0	100%	0.9333
4CVU_NAG_A_1005	8%	51%	0.312	0.793	0.44	1.44	-	3	0	0	100%	0.9333
4UOJ_NAG_B_1003	67%	71%	0.129	0.938	0.61	0.48	-	-	0	0	100%	0.9333
1OC7_NAG_A_500	100%	60%	0.04	0.991	0.61	0.9	-	1	0	0	100%	0.9333
1OC6_NAG_A_500	100%	67%	0.041	0.988	0.46	0.8	-	1	0	0	100%	0.9333
1UWC_NAG_A_262	100%	54%	0.046	0.99	0.81	0.95	-	-	0	0	100%	0.9333
6ZE6_NAG_B_703	99%	52%	0.044	0.984	0.78	1.07	-	2	0	0	100%	0.8667
6ZE2_NAG_B_704	99%	56%	0.042	0.979	0.73	0.95	-	1	0	0	100%	0.9333

RCSB PDB Core Operations are funded by the National Science Foundation (DBI-1832184), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.